Although telomerase activity is important in normal immune function, it is unclear whether telomerase or telomerase (dys)regulation plays a role in the pathogenic immune response in autoimmune diseases like rheumatoid arthritis (RA). In this study we evaluated the dynamics of the activation-induced human Telomerase Reverse Transcriptase (hTERT) response in RA patients and non-RA controls. The expression of the catalytic subunit of telomerase, hTERT, was measured in PBMC of RA patients and controls after in vitro stimulation with anti-CD3 monoclonal antibody (mAb) using real-time PCR. Anti-CD3 mAb stimulation induced activation and proliferation of the T cells in all populations studied. In early RA patients with a disease duration of less than a year, the activation-induced hTERT mRNA levels were found to be reduced as compared to healthy controls (HC). Chronic RA patients, with a disease duration of more than one year, did not show these impaired hTERT mRNA levels after stimulation with anti-CD3 mAb. Decreased hTERT mRNA levels were also found in multiple sclerosis patients and patients suffering from flu-like symptoms, indicating that these deviations are not disease-specific. The impaired activation-induced hTERT response in PBMC may be a general response of the immune cells in cases of acute or chronic immuneactivation, presumably to control unwanted clonal expansions and to maintain the diversity of the TCR repertoire. Our results also indicate that clonal T cell expansions, described in RA, are probably not mediated by an elevated potency to express hTERT.
Introduction
Rheumatoid arthritis (RA) is a chronic inflammatory disease that causes irreversible destructions of tendons, cartilage and bone [1] . Despite many years of intensive investigation the etiology of this multifactorial disease has not been revealed yet. However, accumulating evidence indicates that RA is an autoimmune pathology in which T cells play a major role [2] .
With increasing disease duration a number of phenotypic and functional T cell defects have been described in RA including hyporesponsiveness of T cells to stimulation, a decline in naive CD4+ T cells and a disturbance in the naive T cell receptor (TCR) repertoire indicated by a loss of TCR diversity and clonal expansion of a proportion of T cells [3] [4] [5] . The capacity of lymphocytes to clonally expand may be mediated, at least in part, through the upregulation of telomerase. Telomerase is a large ribonucleoprotein complex that synthesizes telomere repeats to maintain telomere length at a species-specific level. Telomeres shorten progressively with every cell division due to the inability of DNA-polymerase to fully replicate the extreme ends of chromosomes, the so-called end-replication problem [6, 7] . This shortening of telomeres has been proposed to act as a mitotic clock that monitors cell division and provides a measure of the residual replicative capacity of cells [8, 9] . Critically short telomeres may be the signal for replicative senescence and ultimately chromosomal instability in normal somatic cells [10, 11] . Telomere erosion can however be prevented by upregulation or reactivation of telomerase [12, 13] . The two most important subunits are an endogenous RNA subunit, human Telomerase-associated RNA (hTR), which contains a 11-base template sequence for the synthesis of telomere DNA, and the protein catalytic subunit, human Telomerase Reverse Transcriptase (hTERT) with reverse transcriptase activity [14] .
Telomerase is constitutively expressed in germ line cells and in the majority of malignant tumor cells, and is repressed in most human normal somatic cells [15] . In some somatic cell populations, such as lymphocytes and hemopoietic stem cells, there is a highly regulated transient expression of telomerase [9, 16] . Telomerase activity has predominantly been studied in tumor cells, but it may also play a role in autoimmune diseases like RA. The aim of this study was to reveal the role of telomerase activity in the pathogenesis of RA. To this end the dynamics of the activation-induced hTERT response was evaluated in early and chronic RA patients and in controls consisting of healthy controls (HC), patients suffering from flu-like symptoms and multiple sclerosis (MS) patients.
Materials and methods

Patients and controls
The activation induced hTERT mRNA levels were studied in peripheral blood samples from 15 RA patients and 23 control subjects. All RA patients fulfilled the 1987 American College of Rheumatology criteria for the diagnosis of RA. RA patients were subdivided in early and chronic RA patients according to their disease duration. All chronic RA (cRA) patients were treated with disease-modifying anti-rheumatic drugs (DMARDs). All early RA patients (eRA) had a RA disease duration of less than a year and had not been receiving treatment prior to blood sampling. RA patients' characteristics are presented in Table 1 . The Disease Activity Score (DAS) and the assessor's global assessment (AGA) score were used as an indicator for disease activity in cRA patients and early RA patients respectively. An AGA of 1 or 2 and a DAS28 lower than 2.6 were considered stable disease. The control group consisted of eight MS is a chronic inflammatory disease of the central nervous system (CNS) and like RA is also considered to be a T cell mediated autoimmune disease [17] .
Culture conditions
PBMC were isolated using Ficoll HyPaque density gradient centrifugation (Sigma, St. Louis, MO, USA). Aliquots of 1x10 6 freshly isolated PBMC were washed with ice cold PBS, pelleted and stored at -80° C until further analysis. PBMC were cultured in vitro in RPMI 1640 (Invitrogen, Merelbeke, Belgium) supplemented with 1 mM sodium pyruvate (Invitrogen), non-essential amino acids (Invitrogen) and 10% fetal bovine serum (Hyclone, Utah, USA) or autologous serum, in the presence of 5% CO 2 at 37°C. To study the kinetics of hTERT mRNA expression and telomerase bioactivity, PBMC were seeded into a 24-well plate (Greiner, Bio-One GmbH) at a concentration of 5x10 5 cells/ml and stimulated with anti-CD3 mAb (2µg/ml) for 8 days. Each day the cells in a single well were collected and pelleted.
On day 1 (after isolation), day 4 and day 8, PBMC were phenotypically characterized by flow-cytometric analysis (FACSCalibur, BD Biosciences, Erembodegem, Belgium) using anti-CD4 FITC, anti-CD4 PerCP, anti-CD8 PE, anti-CD3 PE and anti-CD25 FITC antibodies (BD Biosciences).
Quantitative analysis of the catalytic subunit hTERT
Total RNA was extracted from cell pellets with the High Pure RNA Isolation Kit according to the manufacturer's instructions (Roche Diagnostics GmbH, Mannheim, Germany).
Expression of hTERT mRNA was measured using the LightCycler TeloTAGGG hTERT Quantification Kit (Roche Diagnostics GmbH), a real-time quantitative reverse transcriptase PCR. The housekeeping gene, porphobilinogen deaminase (PBGD), was used as a reference for relative quantification. hTERT and PBGD were amplified in two separate reactions. In brief, 1µl RNA (100-200 ng) was added to a reverse transcriptase / amplification mixture in a total volume of 10 µl. The PCR program used consists of 10 min at 60°C for reverse transcription, 30 sec at 95°C followed by 40 cycles of denaturation (95°C), annealing (10 sec at 60°C) and enzymatic chain extension (10 sec at 72°C).
PCR-based Telomerase activity assay
Telomerase activity was measured using the TeloTAGGG Telomerase PCR ELISA plus kit (Roche Diagnostics GmbH) which combines a telomere repeat amplification protocol ( 
Statistical analyses
Spearman test was used to determine correlation between telomerase activity and hTERT mRNA expression in PBMC. RA patients and non-RA controls were compared using Mann Whitney U test. P-values < 0.05 were considered statistically significant.
Results
Relation between hTERT mRNA expression and telomerase activity in PBMC
The identification of differentially expressed subunits of telomerase indicated a major control point at the level of transcription. There are however other mechanisms that could play a role in the regulation of telomerase. To study the correlation between hTERT mRNA expression and telomerase activity in PBMC, we stimulated PBMC of 3 healthy controls with anti-CD3 mAb for 7 days. Each day both telomerase activity and hTERT mRNA expression were analyzed. Our data show that an increase in telomerase activity was accompanied by an increase in hTERT mRNA expression with a strong positive correlation between both parameters (R² = 0.86, p<0.05)) ( Figure 1 ).
Activation-induced hTERT mRNA levels in PBMC
TCR mediated events, such as anti-CD3 mAb stimulation, can trigger telomerase expression in T lymphocytes [14] . We studied the hTERT mRNA expression profile after stimulation After anti-CD3 mAb stimulation, hTERT mRNA levels gradually increased, peaked shortly, and slowly decreased to the basal levels thereafter (Figure 2A ). The hTERT mRNA expression pattern after stimulation is significantly impaired in eRA patients as compared to HC (p<0.01). Remarkably, MS patients (p<0.01) and patients suffering from flu-like symptoms (p<0.05) also exhibited reduced hTERT mRNA levels ( Figure 2A) . In RA patients, there was no relation between disease status (active versus stable disease) and activationinduced hTERT mRNA levels (data not shown).
Maximum hTERT mRNA level after stimulation
The maximum hTERT mRNA level after anti-CD3 mAb stimulation, which was reached between day 3 and 5, was also evaluated since it may better represent the capacity of PBMC to express hTERT mRNA. The level of maximum hTERT mRNA expression was comparable in PBMC of cRA patients and HC, but was significantly lower in early RA patients compared to both HC (p<0.01) and cRA patients (p<0.05) ( Figure 2B ). However, this phenomenon again is not specific for early RA patients since a reduced maximal hTERT mRNA level was also found in MS patients (p<0.01 as compared to HC) and patients with flu-like symptoms (p<0.05 as compared to HC). As the average age differed between the populations studied, we tested whether there was a relation between age and the maximum level of hTERT mRNA induced by anti-CD3 mAb stimulation. We did not observe a significant correlation between the maximum hTERT mRNA level and age, neither in the HC group nor in the combined eRA, flu and MS group ( Figure 2C ).
Effect of anti-CD3 mAb stimulation on PBMC composition, activation and proliferation
Telomerase activity is highly regulated in T-cells. Its expression is closely linked to activation and subsequent proliferation. We therefore evaluated the T cell activation level and CD4/CD8 composition of the PBMC fraction after stimulation with anti-CD3 mAb by flow cytometry.
The composition of the PBMC fraction in all groups was comparable at the three time-points studied ( figure 3A and 3B ). Anti-CD3 mAb stimulation was effective as it induced T cell activation (CD25 expression) in all populations studied. After 4 days of stimulation, the percentage of activated T cells was comparable in HC, eRA, cRA and MS patients and was even higher in flu patients ( Figure 3C ). Proliferation could be estimated by evaluating the PBGD content of the cells collected from a single well (originating from 1 million cells) as measured by real time PCR. hPBGD is a suitable housekeeping gene for the relative quantification of a low copy gene such as hTERT. Its content will correlate well with cell numbers. Cell numbers after activation were higher in eRA, MS and flu patients and lower in cRA patients as compared to HC ( Figure 3D ), but the differences were not statistically significant. These data indicate that the reduced hTERT mRNA levels in eRA, MS and flu patients after stimulation are not due to a lower T cell response in these patients.
Discussion
Regulation of telomerase activity is a tightly controlled process in which mechanisms like telomerase gene expression (hTERT, hTR), post-translational modifications (protein phosphorylation), protein-protein interactions, and protein delocalization have been implicated [18] [19] [20] [21] . Our data indicate that in activated T cells telomerase activity is primarily regulated at the level of transcription of the hTERT gene. These results imply that in activated T cells telomerase activity can be estimated by measuring hTERT mRNA levels.
An adequate immune response to antigen exposure requires a fast and profound (clonal) expansion of lymphocytes [14, 22] . The expression of telomerase in responding T cells can act to sustain telomere length and replicative capacity during such an immune response [23] .
Although telomerase activity is important in normal immune function [24] , it is unclear whether telomerase or telomerase (dys)regulation plays a role in the pathogenic immune response in autoimmune diseases.
In this study we compared the dynamics of the activation-induced hTERT mRNA levels in RA patients and non-RA controls consisting of HC, people suffering from flu-like symptoms and MS patients. In the majority of both RA patients and controls we were unable to detect hTERT mRNA in freshly isolated PBMC. These data conflict with the findings of some other research groups who were able to detect telomerase activity in PBMC freshly isolated from RA patients and HC [16, 22, 25] . However, our results clearly illustrate that telomerase activity is transiently upregulated after stimulation. This implicates that telomerase activity levels, measured directly ex vivo, are dependent on the moment and extent of the last in vivo activation.
In contrast to PBMC of cRA patients, PBMC of early untreated RA patients have reduced hTERT mRNA levels after in vitro stimulation with anti-CD3 mAb. In MS patients and patients suffering from flu-like symptoms, activation-induced hTERT mRNA levels are also reduced, which suggests that the deviations are not disease-specific. It should be noted that the average age differed between the populations studied. However, Son et al showed that age did not alter the magnitude of telomerase activity induced after in vitro stimulation [26] .
Moreover, we did not observe a decreasing maximum level of hTERT mRNA expression with advancing age suggesting that age may not be a major confounding factor in our study. FACS analysis revealed that T cell activation and proliferation were comparable in the groups studied. This indicates that the reduced hTERT mRNA levels in eRA, MS and flu patients
were not due to hyporesponsiveness of the T cells. However, in contrast to early RA patients, chronic RA patients have a hTERT mRNA expression profile comparable to HC. It has been described by Koetz et al that T cells in cRA patients show an age-inappropriate telomere erosion [27] . These cells apparently have a large replicative history and a decreased capacity to proliferate. As expected, the T cell proliferative response in this patient group seemed to be impaired. It has been demonstrated that lymphocytes from RA patients have an increased sensitivity to die from AICD [28] . A fraction of the proliferative restricted cells may thus undergo apoptosis in response to stimulation. This could lead to an increase in the relative fraction of T cells expressing telomerase, resulting in the near to 'normal' hTERT mRNA levels in cRA patients. Moreover, all chronic RA patients were treated with DMARDs, which could have an influence on hTERT mRNA levels. Results obtained from this patient group may therefore not reflect the natural situation.
In conclusion, our report is the first to study the kinetics of hTERT mRNA levels in PBMC of RA patients and controls following in vitro activation. We have shown that PBMC, which have been challenged extensively during chronic (eRA, MS) or acute inflammation (flu),
show an impaired hTERT mRNA response. This suggests a mechanism of the immune system to control unwanted clonal expansions and maintain the diversity of the TCR-repertoire. Since hTERT mRNA levels are reduced in proliferating PBMC of early RA patients, the clonal expansions described in RA are probably not mediated by an elevated potency to express hTERT mRNA. 
